Tumor necrosis factor alpha sensitizes low epidermal growth factor receptor (EGFR)-expressing carcinomas for anti-EGFR therapy.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Cancer Research

• Publication date

  2001-02-02

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 11221831
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential expression and translocation of protein tyrosine phosphatase 1B-related proteins in ME-180 tumor cells expressing apoptotic sensitivity and resistance to tumor necrosis factor: potential interaction with epidermal growth factor receptor

  1999cited by this paper
• Eradication of established tumors by a fully human monoclonal antibody to the epidermal growth factor receptor without concomitant chemotherapy.

  1999cited by this paper
• EGFR blockade by tyrosine kinase inhibitor or monoclonal antibody inhibits growth, directs terminal differentiation and induces apoptosis in the human squamous cell carcinoma HN5.

  1998cited by this paper
• Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts.

  1998cited by this paper
• Overexpression of c-erbB-3 in Various Stages of Human Squamous Cell Carcinomas

  1998cited by this paper
• Role of epidermal‐growth‐factor receptor in tumor progression in transformed human mammary epithelial cells

  1998cited by this paper
• Activation of EGF receptor family members suppresses the cytotoxic effects of tumor necrosis factor-α

  1998cited by this paper
• Cytokine-mediated enhancement of epidermal growth factor receptor expression provides an immunological approach to the therapy of pancreatic cancer.

  1997cited by this paper
• Epidermal growth factor inhibits cytokine‐induced apoptosis of primary human trophoblasts

  1996cited by this paper
• EGF-effects in vitro and in vivo on a carcinoma cell line rich in EGFR.

  1995cited by this paper
• Effect of tumour necrosis factor on the uptake of specific and control monoclonal antibodies in a human tumour xenograft model.

  1995cited by this paper
• Pharmacokinetics of reshaped MAb 425 in three animal species

  1995cited by this paper
• Growth inhibition of xenotransplanted human carcinomas by a monoclonal antibody directed against the epidermal growth factor receptor.

  1994cited by this paper
• Tumor necrosis factor alpha and gamma-interferon enhancement of anti-epidermal growth factor receptor monoclonal antibody binding to human melanoma cells.

  1993cited by this paper
• Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminedichloroplatinum on well established A431 cell xenografts.

  1993cited by this paper
• Tumor necrosis factor α and γ interferon enhancement of anti-epidermal growth factor receptor monoclonal antibody binding to human melanoma cells

  1993cited by this paper
• Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG.

  1992cited by this paper
• Epidermal growth factor receptor monoclonal antibody inhibits constitutive receptor phosphorylation, reduces autonomous growth, and sensitizes androgen-independent prostatic carcinoma cells to tumor necrosis factor alpha.

  1992cited by this paper
• Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers.

  1991cited by this paper
• Dependence of a human squamous carcinoma and associated paraneoplastic syndromes on the epidermal growth factor receptor pathway in nude mice.

  1991cited by this paper
• Ligand-induced activation of A431 cell epidermal growth factor receptors occurs primarily by an autocrine pathway that acts upon receptors on the surface rather than intracellularly.

  1991influential reference
• Over‐expression of the EGF receptor is a hallmark of squamous cell carcinomas

  1986cited by this paper
• Autocrine growth factors and cancer

  1985cited by this paper

• The in vitro and in vivo anticancer effect of β-2-himachalen-6-ol isolated from the Lebanese Daucus carota spp. carota

  2019cites this paper
• Photodynamic diagnosis with methyl-5-aminolevulinate in squamous intraepithelial lesions of the vulva: Experimental research

  2018cites this paper
• Epidermal growth factor receptor (EGFR) expression in patients with laryngeal squamous cell carcinoma

  2015cites this paper
• ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma

  2014cites this paper
• Epidermal growth factor receptor as a biomarker for cervical cancer.

  2011cites this paper
• EGFR(s) in aging and carcinogenesis of the gastrointestinal tract.

  2010cites this paper
• Targeting epidermal growth factor receptor in solid tumors: critical evaluation of the biological importance of therapeutic monoclonal antibodies.

  2009cites this paper
• Tumor necrosis factor-alpha-stimulated membrane type 1-matrix metalloproteinase production is modulated by epidermal growth factor receptor signaling in human gingival fibroblasts.

  2009cites this paper
• Impact of EGFR immunoexpression on STAT3 activation and association with proinflammatory/regulatory cytokine pattern in laryngeal squamous cell carcinoma.

  2009influential citation
• Tumor necrosis factor and cancer, buddies or foes?

  2008cites this paper
• EGFR-targeted therapy in colorectal cancer: does immunohistochemistry deserve a role in predicting the response to cetuximab?

  2008cites this paper
• Tyrosine kinase inhibitors and cancer therapy.

  2007cites this paper
• Head and neck squamous cell carcinoma cell lines: Established models and rationale for selection

  2007cites this paper
• The Efficacy of Epidermal Growth Factor Receptor–Specific Antibodies against Glioma Xenografts Is Influenced by Receptor Levels, Activation Status, and Heterodimerization

  2007cites this paper
• Epidermal Growth Factor Receptor Inhibition in Non–Small Cell Lung Cancer

  2007cites this paper
• Epidermal Growth Factor Receptor Is Involved in the Development of an Invasive Phenotype in Vulvar Squamous Lesions, but Is Not Related to MIB-1 Immunoreactivity

  2007cites this paper
• EGFR function and detection in cancer therapy.

  2006cites this paper
• The response of human epithelial cells to TNF involves an inducible autocrine cascade.

  2006cites this paper
• Targeting EGFR and HER‐2 receptor tyrosine kinases for cancer drug discovery and development

  2006cites this paper
• EGFR in colorectal cancer: more than a simple receptor.

  2006cites this paper
• Blockade of epidermal growth factor receptor (EGFR) activity.

  2005cites this paper
• Interferon-α Promotes the Anti-Proliferative Effect of Gefitinib (ZD1839) on Human Colon Cancer Cell Lines

  2005cites this paper
• Approaches to optimize the use of monoclonal antibodies to epidermal growth factor receptor

  2005cites this paper
• Epidermal growth factor receptor and signal transduction: potential targets for anti-cancer therapy.

  2005cites this paper
• Epidermal growth factor receptor‐targeted treatment for advanced colorectal carcinoma

  2005cites this paper
• Iressa (ZD 1839) inhibits phosphorylation of three different downstream signal transducers in head and neck cancer (SCCHN).

  2005cites this paper
• Membrane Receptor and Antiangiogenic Targeted Therapies in the Treatment of Cancer

  2005cites this paper
• Interferon-alpha promotes the anti-proliferative effect of gefitinib (ZD 1839) on human colon cancer cell lines.

  2005cites this paper
• Interferon-alpha promotes the anti-proliferative effect of Erlotinib (OSI-774) on human colon cancer cell lines.

  2005cites this paper
• PI3K/Akt signalling pathway and cancer.

  2004cites this paper
• Pharmacokinetic and pharmacodynamic properties of EGFR inhibitors under clinical investigation.

  2004cites this paper
• STAT 3 activation in head and neck squamous cell carcinomas is controlled by the EGFR.

  2004cites this paper
• Induced Autocrine Signaling through the Epidermal Growth Factor Receptor Contributes to the Response of Mammary Epithelial Cells to Tumor Necrosis Factor α*

  2004cites this paper
• Epidermal growth factor receptor as a therapeutic target for the treatment of colorectal cancer.

  2004cites this paper
• Epidermal growth factor receptor inhibitors in clinical development.

  2004cites this paper
• Monoclonal and Bispecific Antibodies in Combination with Radiotherapy for Cancer Treatment

  2004cites this paper
• Prevention of Gynecologic Malignancies

  2004cites this paper
• MONOCLONALAND BISPECIFIC ANTIBODIES IN COMBINATIONWITH RADIOTHERAPYFOR CANCERTREATMENT

  2004cites this paper
• Epidermal growth factor receptor: a promising target in solid tumours.

  2004cites this paper
• Issues and progress with protein kinase inhibitors for cancer treatment

  2003cites this paper
• Therapeutic anticancer antibodies

  2003cites this paper
• Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR) family and its downstream effectors in breast cancer.

  2003cites this paper
• The Role of Growth Factors for Disease and Therapy in Diseases of the Head and Neck

  2003cites this paper
• EGFR antibody-supplemented TPE-chemotherapy. Preclinical investigations to a novel approach for head and neck cancer induction treatment.

  2003cites this paper
• Carcinomas unresponsive to either cisplatinum or anti-EGFR therapy can be growth inhibited by combination therapy of both agents.

  2003cites this paper
• Inhibitors of epidermal-growth-factor receptors: a review of clinical research with a focus on non-small-cell lung cancer.

  2003cites this paper
• Polymorphism at the –308‐promoter position of the tumor necrosis factor‐alpha (TNF‐α) gene and cervical cancer

  2003cites this paper
• The role of epidermal growth factor receptor in head and neck squamous cell carcinoma

  2003cites this paper
• An update of new targets for cancer treatment: receptor-mediated signals.

  2002cites this paper
• Influence of epidermal growth factor receptor (EGFR), p53 and intrinsic MAP kinase pathway status of tumour cells on the antiproliferative effect of ZD1839 (‘Iressa’)

  2002cites this paper
• Proinflammatory cytokines block growth of breast cancer cells by impairing signals from a growth factor receptor.

  2002cites this paper
• Anti-epidermal growth factor receptor drugs in cancer therapy

  2002cites this paper
• Anti‐epidermal growth factor receptor‐antibody therapy for treatment of breast cancer

  2002cites this paper
• Wachstumsfaktoren in der Hals-Nasen-Ohren-Heilkunde

  2002cites this paper